TLRY - ティルレイ (Tilray Inc.) ティルレイ

 TLRYのチャート


 TLRYの企業情報

symbol TLRY
会社名 Tilray Inc (ティルレイ)
分野(sector) Consumer Durables   耐久消費財
産業(industry) Specialty Chemicals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 ティルレイ(Tilray Inc)は医薬品分野に従事するカナダを拠点とする企業である。同社はカンナビス製品を医薬品販売業者に供給する。同社は医療カンナビスの研究、栽培、加工および世界中のカンナビス製品の販売に焦点を当てる。また、オーストラリア、カナダ、ドイツの子会社を通じて5大陸にまたがる多数の国の患者にカンナビス製品を供給し、カナダおよびヨーロッパで医療用カンナビスを生産する。   ティルレイはカナダ医薬品企業。主に医療用大麻の製造・販売に従事する。同社は大麻に含まれる化学物質カンナビノイドをベ―スとする医薬品を、カナダ国内およびアルゼンチン、オ―ストラリア、チリ、クロアチア、キプロス、チェコ、ドイツ、ニュ―ジ―ランド、南アフリカにおいて販売する。本社所在地はブリティッシュ・コロンビア。   Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.
本社所在地 1100 Maughan Road Nanaimo British Columbia V9X IJ2 CAN
代表者氏名
代表者役職名
電話番号 +1 416-934-2141
設立年月日 43101
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数 330人
url www.tilray.com
nasdaq_url https://www.nasdaq.com/symbol/tlry
adr_tso
EBITDA EBITDA(百万ドル) -17.20800
終値(lastsale) 139.77
時価総額(marketcap) 13018742750.34
時価総額 時価総額(百万ドル) 12290.36
売上高 売上高(百万ドル) 28.07100
企業価値(EV) 企業価値(EV)(百万ドル) 12319.77
当期純利益 当期純利益(百万ドル) -22.69000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Tilray Inc revenues increased 75% to $17.6M. Net loss increased from $3.1M to $18M. Revenues reflect Canada (Country) segment increase from $5M to $17M other countries segment increase from $0K to $540K. Higher net loss reflects General and administrative expenses - Ba increase from $3.9M to $10M (expense) Stock-based compensation expense increase from $69K to $5.6M (expense).

 TLRYのテクニカル分析


 TLRYのニュース

   Enslaving stocks: Tilray, Inc. (NASDAQ:TLRY -2.02%), Freeport-McMoRan Inc. (NYSE:FCX 0.19%)  2021/09/03 22:05:35 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Enslaving stocks: Tilray, Inc. (NASDAQ:TLRY -2.02%), Freeport-McMoRan Inc. (NYSE:FCX 0.19%) appeared first on Stocks Equity .
   Tilray stock forecast: can TLRY recover after 80% losses?  2021/09/03 16:00:00 Capital Com
Shares in the Canadian firm have plummeted dramatically so far in 2021. What does that mean for the Tilray share price forecast? Read on to find out. Read More
   Timber Point Global Allocations Fund Buys iShares 20+ Year Treasury Bond ETF, iShares Gold ...  2021/08/31 22:38:02 GuruFocus
Related Stocks: SWBI , BA , NNDM , OTRK , HCDI , TLT , IAU , AAPL , AMZN , PHO , TLRY , XLI , KRE , RVT , TLRY , TLRY , XLI ,
   Why Tilray''s Stock Looks Like It''s Beginning To Reverse  2021/08/31 21:28:21 Benzinga
Tilray Inc (NASDAQ: TLRY ) shares are trading higher Tuesday, moving alongside other popular cannabis names. The overall sector is moving higher as continued optimism on cannabis legalization is possibly a factor. Tilray was up 4.27% at $13.69 at last check Tuesday afternoon. Tilray Daily Chart Analysis Shares have been falling and look like they could be ready to start turning around if they are able to break out of what technical traders call a falling wedge pattern. The stock has been getting condensed between narrowing highs and lows and is now nearing the point Full story available on Benzinga.com
   Cannabis Stocks: Why Are ACB, CGC, TLRY, SNDL Stocks Turning Green Today?  2021/08/31 19:56:50 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here''s what investors are watching today in the cannabis sector, as a host of the most popular cannabis stocks take off. The post Cannabis Stocks: Why Are ACB, CGC, TLRY, SNDL Stocks Turning Green Today? appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom Americas #1 EV Stock Still Flying Under the Radar
   Marks Wealth, LLC Buys SPDR Oil & Gas Exploration and Production ETF, Materials Select ...  2021/07/13 22:38:12 GuruFocus
Related Stocks: XOP , XLB , JPST , VTIP , VGSH , XLP , AHT , TLRY , OXY , TLRY , IYG , XAR , VGT , NIO , AMC ,
   Tilray CEO expects U.S. cannabis legalization in next 24 months  2021/07/13 20:21:31 Seeking Alpha
   TL Private Wealth Buys Tilray Inc, Tilray Inc, Sells First Trust Dow Jones Internet Index Fund, ...  2021/07/13 18:38:15 GuruFocus
Related Stocks: TLRY , TLRY , FDN , SPCE , SRNE ,
   Cannabis Market Size, Forecast to 2027 - COVID-19 Impact and Global Analysis By Aphria, Aurora Cannabis, Cannabis Science, Medical Marijuana, VIVO Cannabis, Tikun Olam, Tilray, The Cronos Group  2021/07/13 12:28:20 OpenPR
The Cannabis Market is expected to reach US$ 147,457.4 million by2027 from US$ 14,383.8 million in 2019; it is estimated to grow at a CAGR of 29.1% from 2020 to 2027. The insight Partners Research has recently added a
   TLRY Stock: 3 Great Reasons to Buy Tilray  2021/07/12 19:54:02 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tilray has been lumped in with other social media meme stocks. TLRY stock is high-risk, but there''s a lot for long-term investors to like. The post TLRY Stock: 3 Great Reasons to Buy Tilray appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now It doesnt matter if you have $500 in savings or $5 million. Do this now.
   Video: Benzinga Cannabis Insider 4/23 | ETFs, Michigan Market, Verano, Tilray, GrowGen & More!  2021/04/24 17:06:00 Benzinga
Benzinga’s Cannabis Insider is a live daily show for cannabis investors. On Friday’s show, hosts Patrick Lane and Javier Hasse discussed the latest news in the cannabis industry and analized the Michigan cannabis market. Lane and Hasse also had time to look into the following publicly-traded companies and ETFs: AdvisorShares Pure … Full story available on Benzinga.com
   A top Wall Street analyst lays out how a US marijuana decriminalization 'compromise scenario' could spark an M&A boom  2021/04/21 13:05:21 Business Insider
Summary List Placement The House on Monday evening passed the SAFE Banking Act , a modest cannabis reform bill, for the second time in as many years. But the legislation is unlikely to be introduced in the Senate, according to a top Wall Street analyst. Cantor Fitzgerald analyst Pablo Zuanic said in a Tuesday note that he expects key parts of the SAFE Act to end up in a more comprehensive cannabis reform bill being crafted by Senate Majority Leader Chuck Schumer, rather than be introduced as a standalone piece of legislation. If that bill passes, it would catalyze a wave of M&A in the US, driven by well-capitalized Canadian companies, Zuanic said. These companies would probably strike deals to buy stakes in US cannabis firms once that became permissible, he said. Big Canadian companies listed on major stock exchanges like Canopy Growth, Aurora, Tilray, and Aphria, are all preparing to enter the US market as soon as they can, Insider previously reported . "All eyes are on the US market," David Culver, Canopy Growth's Washington DC-based VP of government relations told Insider in an interview. "That's the prize." The SAFE Banking Act would allow US cannabis companies access to the banking system like any other industry.
   Aphria CEO Discusses Tilray Merger On 420, Says Combined Company 'Will Be Ready' For US Legalization  2021/04/20 22:27:18 Benzinga
Aphria Inc (NASDAQ: APHA ) CEO Irwin Simon appeared on CNBC’s "Squawk on the Street" Tuesday to discuss the cannabis company's pending merger with Tilray Inc (NASDAQ: TLRY ). Aphria shareholders voted overwhelmingly in favor of the merger with Tilray, and Tilray is holding its vote on April 30. “We will get the vote done, I’m very confident of that. As I’ve said before, the merger of the two companies will … Full story available on Benzinga.com
   Tilray And Canopy Growth Need A Trend Change: Could SAFE Act Save Them?  2021/04/20 17:38:16 Benzinga
4/20 celebrations come during a seasonally bearish time for cannabis-related stocks. Bulls can still find bullish setups and over-sold bounces, however, and long-term investors can find good entries at the bottom of trends. Tilray (NASDAQ: TLRY ) and Canopy Growth Corporation (NASDAQ: CGC ) have been trending downwards since reaching 52-week highs on Feb. 10. While spring and summer usually cause a low-volume lull in cannabis stocks, the possibility of cannabis-friendly policy moves in the U.S., such as the passage of the SAFE Banking Act through the Senate, could change the trend this year. The Canopy Chart: Canopy Growth has been trading in the gap it left behind on Jan. 6 for the past six trading days. Canopy Growth’s stock has been trading in a textbook-perfect downtrend since March 16, making lower highs and lower lows on … Full story available on Benzinga.com
   No Reefer Madness Here: 5 Cannabis-Focused Stocks For The 420 Trader  2021/04/20 17:27:15 Benzinga
Investors looking to take their portfolios one toke over the line may wish to consider taking a look – preferably sober and without the narcotizing stimulation from the celebrated wacky weed – at the following quintet of cannabis industry-focused stocks. ETFMG Alternative Harvest ETF (NYSE: MJ ) Founded in 2014 and headquartered in Summit New Jersey, this is the largest cannabis-focused exchange-traded fund on the market and the first and only U.S.-listed ETF to target the global cannabis industry directly, via the Prime Alternative Harvest Index. The top holding in this ETF’s portfolio is the 10.35% share of Britain’s GW Pharmaceuticals plc (NASDAQ: GWPH ), followed by a 9.88% share of Canada’s Aphria Inc. (NASDAQ: APHA ) and a 7.01% share of Tilray Inc. (NASDAQ: TLRY ). On Dec. 4, 2020, this ETF reached the mark of $1 billion assets under management. MJ trades around at $20.18, which is between its 52-week high of $34.58 and its 52-week low of $10.12 See Also: Cannabis Insider | Benzinga’s Cannabis Trading For Cannabis Investors cbdMD (NYSE: YCBD ) Founded in 2015 and headquartered in Charlotte, North Carolina, this company offers a line of consumer hemp-based cannabidiol (CBD) products, including gummies, tinctures, vape oils, topicals, bath bombs and pet products for the U.S. market.

 関連キーワード  (医薬品 米国株 ティルレイ TLRY Tilray Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)